chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning an adult patient who " over the last week", on approximately 07-OCT-2005, was vaccinated with a 0.5 ml intramuscular dose of pneumococcal 23v polysaccharide vaccine (lot 650453/0791P).  It was reported that the patient developed a severe local reaction at the injection site including, redness, swelling, and pain.  The patient was seen at the emergency room.  It was reported that the patient had recovered or was recovering.  The reporter expressed concern about the lot 650453/0791P for pneumococcal 23v polysaccharide vaccine.  Additional information has been requested.  A lot check has been requested.  The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory.  The lot complies with the standards and was released.
Patient didn?t receive  email for second dose appointment. SHE CAME AS A WALK IN 47 DAYS after first dose. Dose was still administered.
had the third vaccine and got shingles/suspected vaccination failure; shingles; worse burning; itchy; Pain; had the third vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 3rd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, burning sensation, pruritus, pain and extra dose administered.On an unknown date, the outcome of the vaccination failure, shingles, burning sensation, pruritus, pain and extra dose administered were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, burning sensation, pruritus and pain to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine.   Additional details were reported as follows: This case was reported by the patient for herself/himself. The age at vaccination was not reported. The patient had the 3rd Shingles vaccine, which led to extra dose administered and he/she got shingles and had worse burning itchy pain. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure, since the details regarding the time to onset and laboratory confirmation for shingles were not provided.
Patient had mild headache and localized site reaction the night of injection, 4/2/13. Gotten worse into second day.
Patient has left arm numbness after his 2nd pfizer covid vaccine. He states that exercise helps. It is not a pins/needles feeling, but more of a whole arm numbness, Patient reports that it happens every other day. Pt states it did not happen between his first and second dose; it started only after his second dose.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. On 28-OCT-2014 the patient was vaccinated with a dose of ZOSTAVAX (lot # K008881, expiration date: 20-SEP-2015), 0.65 ml, subcutaneous. Concomitant therapies included LIALDA. On an unknown date in 2014, after vaccination, the patient experienced unspecified event. The outcome of unspecified event was unknown." The patient sought medical attention and was prescribed amoxicillin and MEDROL pack as a treatment for the event. The relatedness between the event and ZOSTAVAX was not reported. Additional information has been requested.
Patient received FLUZONE HIGH DOSE to the left arm on 10/21/15 and returned to pharmacy today 11/1815 and said his arm is still hurting.
Approximately 20 minutes after vaccine administration, patient developed generalized urticarial.  No respiratory or GI symptoms.  Re-evaluated in the office, normal cardiac and lung exam.  Diffuse urticarial and pruritus.  Given 5mg PO chewable Claritin and applied topical triamcinolone.  MOC called back about 3 hours later and symptoms had resolved.
Parsonage Turner Syndrome.   Severe debilitating pain in right shoulder beginning 2/2/2021 that became progressively worse throughout the day. Decreased range of motion, unable to lift/move arm by evening. The following day range of motion gradually returned but was clunky and limited. Over the next 4 days profound weakness with intermittent sharp stabbing pain in the joint. Utilized ibuprofen, Tylenol, flexeril, and heat with minimal relief.  PCP 2/11/2021 prescribed medrol dose pack, x-ray shoulder,  mri shoulder and referral to ortho. 2/11/2021 X-ray normal. 2/24/2021 Mri showed disfuse fluid signal with recommendation to pursue neurogenic approach. Saw Ortho on 2/19/2021. They ordered PT, scheduled to begin 3/17/2021 (first available). Spoke with PCP 3/1/2021, referral to physiatry placed for EMG and possible joint injection.  Have been utilizing NMES and doing basic range of motion exercises.   Continue to have severe muscle weakness.
Felt sick/ill; Horrendous cramping in her gut; Was nauseated; Vomit; Pain; she wanted to die because the pain is so intense; This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th September 2019, the patient received the 1st dose of Shingrix. In October 2019, couple of days after receiving Shingrix, the patient experienced feeling unwell, intestinal cramps, nausea, vomiting, pain and feeling abnormal. On an unknown date, the outcome of the feeling unwell, intestinal cramps, nausea, vomiting, pain and feeling abnormal were not recovered/not resolved.   It was unknown if the reporter considered the feeling unwell, intestinal cramps, nausea, vomiting, pain and feeling abnormal to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient herself. A couple of days after vaccination, the patient experienced horrendous cramping in her gut, she was nauseated and vomited, claimed to felt sick and the symptoms would last 6 to 8 hours and then would subside and the next day she would go through the same thing again. On 11th October 2019, on Friday, the stool analysis for the samples was done at her physician's office and the results were awaited, but the patient believed that her reactions were related to the Shingrix vaccine. The patient claimed that on this past Saturday, 12th October 2019, she had no cramping but on Sunday the symptoms started again for 4 hours rather than the typical 6 to 8 hours. The patient also claimed that she wanted to die because the pain was so intense. The patient also stated that it was not uncommon for her to have the worse side effects from medications. The reporter consented to follow up. As the reporter is not a health care professional, her causality is not considered.
Pt became pale & limp /p arrival home; later had an episode of turning pale /w out limpness. No cyanosis or resp. problems
Patient showed reaction to vaccine almost immediately, began having chills and nausea. Patient ultimately succumbed to cardiac arrest.
Left deltoid area swollen; Left deltoid area red; Fluid-filled blisters; This is a spontaneous report from a contactable nurse. the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via intramuscular route of administration in the left arm on 25Jun2021 at 08:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Jun2021, the patient experienced left deltoid area swollen, red and fluid-filled blisters. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left deltoid area swollen, red and fluid-filled blisters was resolved on an unknown date in 2021.
Narrative:  Patient was not feeling well 2 weeks after Covid vaccination and developed a saddle pulmonary embolism with no prior history
Chills began around 9:30 pm lasted about 5 hours Headache worsened around 10pm, lasted about 12 hours Nausea began around 1 am, lasted about 2 hours Aches began around 10 pm, lasted about 12 hours
Rash on chest, neck, arms, back, feet.  Severe itching. Upper left arm swollen and red.
Received booster, left facility and entered my vehicle. Left facility parking lot by car, injection site felt tingly and I became lightheaded and dizzy. Attempted to pull car over however blacked out while driving, crashed car and had to be woken up by witness to crash, I was not required or told by pharmacy to wait for observation after booster was administered. No bodily injury to myself or anyone else, just property damage and auto damage.
No adverse events.  Adult was vaccinated with pediatric dose of Hepatitis B Engerix B.
Red rash all over skin (armpits, chest, face, legs, back),  inflammation, swelling and itchiness
Information has been received from a physician concerning a female who was vaccinated with a 0.5 ml dose of Gardasil. Subsequently the patient experienced injection site soreness and dizziness. Unspecified medical attention was sought. Additional information has been requested.
? My son, was born a beautiful child with a 10 APGAR at birth. After the 3 and 6 month DPT vaccinations administered by Hospital, he developed a fever of 105. I took him to Hospital emergency room where they put him in an ice bath. After the third DPT vaccination at 11 months, he basically died in my arms. He had 3 tonic clonic (Grand-mal) seizures over a period of 5 hours. He turned purple, stopped breathing and went limp in my arms. I gave him mouth to mouth resuscitation until the paramedics came. His neurologist, Dr. administered an EEG and determined him to have abnormal brain activity and epilepsy. His diagnosis came with a Phenobarbital prescription. He lost his agility, his normal appetite and was extremely lethargic. I cried out to God to help return him to his beautiful happy health. To bear the burden of sorrow knowing that IF we had known these heinous drugs would inflict such harm is crushing. Son has suffered a life time of neuro paralysis and seizures from the DPT vaccination.
Patient developed a localized red and warm area below the site of immunization measuring approximately 6 inches by 3 to 4 inches. Patient c/o pain at the injection site. Cellulitis evident. Pt started on cephalexin 500mg PO Q6 hours x 10 days.
I got the Recombinant Zoster (Shingle) Vaccine, RZV. I'm not sure if that is the one I selected above. The muscle of the injection site got moderately sore. And is still mildly sore today. I also had moderate Headache, muscle aches, fever, shivering and fatigue. Those symptoms lasted at the moderate level for two days, then went away, leaving me feeling exhausted/fatigued to this day.  On 04/12/2019 a red rectangle about 2 inches by four inches appeared around the injection site.  No additional pain/soreness and no itching. This is gone now.
This is a spontaneous report received from a contactable consumer or other non-HCP (patient's parent). A 16-year-old female patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), at the age of 16, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Vaccination history included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), at the age of 16, for COVID-19 immunization. The patient experienced dizziness and vertigo, with outcome of unknown. No follow-up attempts needed. information about batch/lot number cannot be obtained.
Patient received COVID vaccine at approximately 1630. Patient verbalized shortness of breath and tightness in chest at approximately 1637. 911 was called. Responders arrived within 3 minutes of placing the call. Responders took the patient to a local emergency department.
Pt. pulled arm away during administration of injection of KINRIX. Mother reports pt. had large red circle around area of injection approx. 3 inches in diameter, red, hot touch for 2 days.
itching & erythema w/knot @ inj site began AM p/vax;the next day exp stiffness & aching joint in lt jaw;did not feel ill @ anytime & had not fever;sx began improving 4MAY98;
I had breakthrough bleeding (menstruating) every day (including day of injection) for 5 months straight, and then a super heavy period, going through 1 pad an hour, and breakthrough bleeding for 2 more months after that.
Information has been received from a consumer concerning his wife, and follow up information has been received a Nurse Practitioner concerning the patient, a 47 year old obese female diabetic (well-controlled) with high cholesterol, high blood pressure, fibromyalgia, an allergy to penicillin, venous insufficiency, and a Basal Metabolic Index (BMI) of 35, who in 2005 was vaccinated with a first dose of Pneumovax 23. Concomitant therapy included metformin, COREG, quinapril HCl, estradiol, simvastatin (MSD), LEXAPRO, LUNESTA, ADDERALL TABLETS, KADIAN, LASIX, cyclobenazeprine HCl (MSD), and MSIR. In December 2006, the patient received Pneumovax 23 two years in a row. An unspecified flu shot was given at the same time. Since then she has had edema of both arms and legs. The day she received Pneumovax 23 vaccine her arm began to swell around the injection site, then spread to her back, shoulders, torso and legs. She then developed edema. It was reported that her feet and legs were discolored and that "her skin is so tight it looks like it may break." The patient was seen by an endocrinologist and later by a cardiologist who ruled out congestive heart failure. The patient was treated with LASIX 80 mg TID. She was complaining of neuropathy symptoms. The patient's symptoms persisted. Additional information has been requested.
administer expired vaccine to patients, after the manufacture date of expiration.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration.) in a 60-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 13-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration.) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 173 doses.  Dates of administration of vaccine were reported as 8Apr2022, 12Apr2022 and 13Apr2022.  The vial did not undergo any temperature excursions.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received contain Non significant information.
Confusion, Headache, Sedation, Myalgia, Arthralgia & Fever Narrative: Employee c/o H.A., muscle,bone pain and aches, fever, chills, loss of energy, foggy brain.
Patient was given initial dose of Gardasil vaccine in (R) deltoid.  Almost immediately after vaccine was given she c/o dizziness & then lost consciousness.  Was sitting in a chair and was able to elevate her legs on another chair.  Regained consciousness after about 10 secs.  Transferred her to a table where she laid with legs elevated 10 min.  Provided juice to client.  Cont'd to feel shaky after 25 min. Phoned he mom who picked her up & drove her home.  B/P 110/70 HR50.
Feeling of tingling midline that radiated down mid chest to l/r; feeling of cold; no sob; no chest pain; No heart or lung hx; Ambulatory with crew; requested transport for followup as recommended by Dr. Transported to Hospital. BP 185/70 at 1543 BP 175/82 at 1549
I probably noticed the next morning, my arm was very stiff and a little numb. It was hurting on and off during the day, intermittently the days following, Pain level 6-7. It lasted 5 days. A little itchy.
How long does a reaction last from a Moderna booster; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (How long does a reaction last from a Moderna booster) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (How long does a reaction last from a Moderna booster). At the time of the report, IMMUNISATION REACTION (How long does a reaction last from a Moderna booster) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Oct-2023: Non-significant follow up received.
Rash on arms and chest. As the day progressed, rash appeared on neck, legs, torso, and back. Used Benadryl before bed on 09/23/10. Still have rash on 09/24/10 with no improvement. Rash is prickly/itchy.
Fever, NauseaVomiting, Chills, Body ache, Malaise Narrative:
Pt called and said that she received the vaccine in her left arm this afternoon. Her arm started to hurt and the entire left side of her body was feeling "heavy". I advised her to go to urgent care or emergency room to seek immediate medical attention.
Information has been received from a LPN concerning a 64 year old female with diabetes, gastroesophageal reflux disease (GERD) and an allergy to PCN who on 10/17/03 was vaccinated with a first or second dose of pneumococcal 23v polysaccharide vaccine (Lot #644105/0820M). Concomitant therapy included glipizide (Glucotrol), lansoprazole (Prevacid), and oxybutynin chloride (Ditropan). Subsequently, the pt developed cellulitis of the left upper arm. Unspecified medical attention was sought and the pt was treated with an unspecified antibiotic. Subsequently, the pt's condition resolved. No product quality complaint was involved. Upon internal review, cellulitis of the left upper arm was determined to be an other important medical event (OMIC). It was also reported that another female pt was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (Lot #644105/0820M) and developed a local reaction with erythema (WAES # 0311USA00696).  It was noted that the physician was concerned about the size of the reactions since both pt's received doses from the same lot number. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
Pt came to the pharmacy where she  received the vaccine with red and  swollen arm. She went to the hospital previously where she was prescribed with benadryl and azithromycin.
pain in right chest or heart(?) 1/2 hour after shot every minute for about 15 min. Nothing after that. Left arm sore for 1 day
Noticed red rash on upper right arm, site of injection, on 2/18/2021.  Rash spread to back, sides, stomach and upper left arm by 2/20/2021.  Was fairly itchy.  Felt like ripples across my back.  On 2/23/2021 itchiness seemed to start to decrease.  Red rash and itchiness is mostly gone by 3/3/2021.  Throughout event I applied dry skin lotion, Shikai Borage Therapy, which seemed to reduce itchiness a bit.  Consulted primary physician 2/23/2021 who advised Benadryl but I did not use it.
First symptoms within 24 hrs of shot: skin redness & swelling, very tender to the touch at injection site. This area affected was 1.75 inch diameter at injection site.  These symptoms declined by 50% or more the next few days. At day 8, I noticed new sensation of soreness under left arm (injection arm) lymph node tender.  Also itching at injection site, plus new swelling-hard lumpy & warm to touch at injection site.
Received pneumonia shot 2 days ago in that area. Tonight she had onset of pain and redness. She noticed the pain first and when she looked it was red.
Moderna 2/13/21, 3/14/21, 9/7/21. Positive on 11/25/22
After the 1st vaccine, 2-3  round bruise-like spots appeared on my left inside forearm.  Then a few days later, the same kind of round spot appeared beneath my belly button.  Then around July 7, another appeared to the left of my stomach.  And now, one is on the inside of my right calf, and then a couple days later, the same kind of spot appeared on the inside of my left calf.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 54-year-old female patient who received SHINGRIX for prophylaxis. On 12th September 2018, the patient received SHINGRIX (subcutaneous). On 12th September 2018, 1 hr after receiving SHINGRIX, the patient experienced injection site swelling and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site swelling was recovering/resolving and the outcome of the intramuscular formulation administered by other route was unknown. It was unknown if the reporter considered the injection site swelling to be related to SHINGRIX. Additional details were provided as follows: The patient inadvertently received SHINGRIX via the subcutaneous route rather than indicated intramuscular route, which led to incorrect route of vaccine administration. One hour following vaccination, the patient experienced swelling at the injection site. On 14th September 2018, the patient visited her physician for swelling at the injection site. The reporter stated that the swelling was improved but not resolved, at the time of reporting. No lot number or expiry date was provided as SHINGRIX was administered at another facility.
mild tingling in both of his arms and hands; mild numbness; This is a spontaneous report from a contactable consumer. A 54-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number and Expiration date: Not reported), via an unspecified route of administration, administered in Arm Left on 17Jun2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included calcitriol (VITAMIN D) for 8 months, fish oil been taking for many years, zinc been taking it for 8months, multivitamin been taking for 8 months all ongoing. On 17Jun2021 He experienced mild numbness and tingling in arms and hands (both started 5hrs after vaccination) and the symptoms were gone in 48 hours. Outcome of recovered events was recovered on 19Jun2021.  Information on the lot/batch number has been requested.